HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Florencia Cidre-Aranaz Selected Research

Biomarkers (Surrogate Marker)

12/2022ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.
1/2022Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1.
1/2021Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma.
11/2020Sarcoma treatment in the era of molecular medicine.
1/2020Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinoma.
1/2019Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Florencia Cidre-Aranaz Research Topics

Disease

15Ewing Sarcoma (Sarcoma, Ewing)
01/2023 - 01/2015
14Neoplasms (Cancer)
01/2023 - 02/2016
5Sarcoma (Soft Tissue Sarcoma)
10/2022 - 02/2016
3Genetic Translocation (Chromosomal Translocation)
11/2019 - 01/2015
2Neoplasm Metastasis (Metastasis)
01/2023 - 01/2022
1Breast Neoplasms (Breast Cancer)
01/2023
1Alveolar Rhabdomyosarcoma
10/2022
1Myxoid Liposarcoma
04/2022
1Genomic Instability
01/2021
1Adenocarcinoma
01/2020

Drug/Important Bio-Agent (IBA)

8Transcription Factors (Transcription Factor)IBA
12/2022 - 01/2015
6Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2019
4Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2021
2CholesterolIBA
12/2022 - 12/2022
2DNA (Deoxyribonucleic Acid)IBA
10/2022 - 09/2015
2Oncogene Proteins (Oncogene Protein)IBA
12/2019 - 02/2016
2Proto-Oncogene Proteins c-etsIBA
11/2019 - 01/2018
1Hypoxia-Inducible Factor 1IBA
01/2023
1Lysine AcetyltransferasesIBA
01/2023
1Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA
01/2023
1Oxygen (Dioxygen)IBA
01/2023
1PalmitatesIBA
01/2023
1Acetyl Coenzyme A (Acetyl-CoA)IBA
01/2023
1NF-kappa B (NF-kB)IBA
01/2023
1ProteomeIBA
12/2022
1ChromatinIBA
12/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2022
1Subfamily A ATP Binding Cassette TransporterIBA
12/2022
1Adenosine Triphosphate (ATP)IBA
12/2022
1Interleukin-15 (Interleukin 15)IBA
10/2022
1CytokinesIBA
10/2022
1Polo-Like Kinase 1IBA
01/2021
1Antineoplastic Agents (Antineoplastics)IBA
01/2021
1resazurinIBA
01/2021
1LigandsIBA
07/2020
1Programmed Cell Death 1 ReceptorIBA
07/2020
1Immune Checkpoint InhibitorsIBA
07/2020
1Death Domain ReceptorsIBA
07/2020
1Adenosine Monophosphate (AMP)IBA
01/2019
1RNA (Ribonucleic Acid)IBA
02/2016
1EWS-FLI fusion proteinIBA
01/2015

Therapy/Procedure

6Therapeutics
10/2022 - 02/2016
1Subcutaneous Injections
01/2021
1Investigational Therapies (Experimental Therapy)
12/2019
1Precision Medicine
11/2019
1Combined Modality Therapy
02/2016